Subscribe
shutterstock_1650524983_sundry_photography
Sundry Photography / Shutterstock.com
13 August 2020AmericasRory O'Neill

BGI wins partial lifting of Illumina injunction

Beijing-based  BGI Genomics can continue to develop its DNA sequencing technology pending an appeal in a patent dispute with  Illumina, a US federal court has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility